Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 1.00 |
| ▸ | MEN1 | O00255 | 6/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 6/20 | 1.00 |
| ▸ | ABCG2 | Q9UNQ0 | 6/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 5/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 4/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 3/20 | 1.00 |
| ▸ | APP | P05067 | 4/20 | 0.89 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.89 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.89 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.80 |
| ▸ | MAOB | P27338 | 3/20 | 0.76 |
| ▸ | CTSL | P07711 | 1/20 | 0.76 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL633177 | 1.00 | MAPT (1.00) | MAPTMEN1KMT2AABCG2MAPK1 | |
| SCHEMBL25219780 | 1.00 | MAPT (1.00) | MAPTMEN1KMT2AABCG2MAPK1 | |
| SCHEMBL30384538 | 0.94 | ABCG2 (1.00) | MAPTMEN1KMT2AABCG2MAPK1 | |
| SCHEMBL30382670 | 0.94 | ABCG2 (1.00) | MAPTMEN1KMT2AABCG2MAPK1 | |
| SCHEMBL25189208 | 0.94 | ABCG2 (1.00) | MAPTMEN1KMT2AABCG2MAPK1 | |
| SCHEMBL634186 | 0.94 | ABCG2 (1.00) | MAPTMEN1KMT2AABCG2MAPK1 | |
| SCHEMBL634187 | 0.94 | ABCG2 (1.00) | MAPTMEN1KMT2AABCG2MAPK1 | |
| SCHEMBL30383218 | 0.93 | ABCG2 (0.91) | MAPTMEN1KMT2AABCG2MAPK1 | |
| SCHEMBL5515061 | 0.93 | ABCG2 (0.91) | MAPTMEN1KMT2AABCG2MAPK1 | |
| SCHEMBL5515065 | 0.93 | ABCG2 (0.91) | MAPTMEN1KMT2AABCG2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECH INC (US) | 2026-04-09 | — | — | US | claimed |
| EP-4655410-A2 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | Symrise AG (DE) | 2025-12-03 | — | — | EP | claimed |
| EP-4496476-A1 | GAS PHASE TREATMENT OF PRODUCE | Apeel Technology, Inc. (US) | 2025-01-29 | — | — | EP | claimed |
| CN-119156138-A | Vapor treatment of agricultural products | 阿比尔技术公司 | 2024-12-17 | — | — | CN | claimed |
| WO-2024156359-A1 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | SYMRISE AG (DE) | 2024-08-02 | — | — | WO | claimed |
| WO-2024156879-A2 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | SYMRISE AG (DE) | 2024-08-02 | — | — | WO | claimed |
| CN-117320559-A | Edible coating with antimicrobial properties | 阿比尔技术公司 | 2023-12-29 | — | — | CN | claimed |
| WO-2023183341-A1 | GAS PHASE TREATMENT OF PRODUCE | APEEL TECHNOLOGY, INC. (US) | 2023-09-28 | — | — | WO | claimed |
| EP-4090167-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | Apeel Technology, Inc. (US) | 2022-11-23 | — | — | EP | claimed |
| US-20220330565-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECHNOLOGY, INC. | 2022-10-20 | — | — | US | claimed |
| WO-2022217089-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECHNOLOGY, INC. (US) | 2022-10-13 | — | — | WO | claimed |
| EP-1888174-B1 | USE OF CHALCONES FOR THE TREATMENT OF VIRAL DISORDERS | JOHNSON & JOHNSON CONSUMER (US) | 2012-02-22 | — | — | EP | claimed |
| US-7763287-B2 | Extract of Cercis chinensis having anti-oxidant activity and anti-aging activity, and cosmetical composition containing the extract for anti-oxidation, skin-aging protection and wrinkle improvement | HANKOOK PHARM. CO., INC. (KR) | 2010-07-27 | — | — | US | claimed |
| US-20080187610-A1 | EXTRACT OF CERCIS CHINENSIS HAVING ANTI-OXIDANT ACTIVITY AND ANTI-AGING ACTIVITY, AND COSMETICAL COMPOSITION CONTAINING THE EXTRACT FOR ANTI-OXIDATION, SKIN-AGING PROTECTION AND WRINKLE IMPROVEMENT | HANKOOK PHARM. CO., INC. (KR) | 2008-08-07 | — | — | US | claimed |
| EP-1888174-A1 | USE OF CHALCONES FOR THE TREATMENT OF VIRAL DISORDERS | Johnson and Johnson Consumer Companies, Inc. (US) | 2008-02-20 | — | — | EP | claimed |
| WO-2006127539-A1 | USE OF CHALCONES FOR THE TREATMENT OF VIRAL DISORDERS | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2006-11-30 | — | — | WO | claimed |
| US-20060270614-A1 | Use of chalcones for the treatment of viral disorders | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | 2006-11-30 | — | — | US | claimed |
| US-20060078633-A1 | Extract of cercis chinensis having anti-oxidant activity and anti-aging activity, and cosmetical composition containing the extract for anti-oxidation, skin-aging protection and wrinkle improvement | HANSAENG COSMETIC CO., LTD. (KR) | 2006-04-13 | — | — | US | claimed |
| EP-4747367-A1 | NEW ENZYMES FOR THE MANUFACTURING OF 4'-O-METHYLATED PHENOLIC SUBSTANCES | Symrise AG (DE) | 2026-05-27 | — | — | EP | disclosed |
| US-20060078633-A1 | Extract of cercis chinensis having anti-oxidant activity and anti-aging activity, and cosmetical composition containing the extract for anti-oxidation, skin-aging protection and wrinkle improvement | HANSAENG COSMETIC CO., LTD. (KR) | 2006-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060078633-A1 | Extract of cercis chinensis having anti-oxidant activity and anti-aging activity, and cosmetical composition containing the extract for anti-oxidation, skin-aging protection and wrinkle improvement | POT1, TERT, TERF2 | MAPT 2594/4885MEN1 3964/4885KMT2A 2116/4885 |
| US-20060270614-A1 | Use of chalcones for the treatment of viral disorders | HAVCR2, HMGB3, EIF2AK2 | MAPT 788/4885MEN1 3326/4885KMT2A 4014/4885 |
| US-20080187610-A1 | EXTRACT OF CERCIS CHINENSIS HAVING ANTI-OXIDANT ACTIVITY AND ANTI-AGING ACTIVITY, AND COSMETICAL COMPOSITION CONTAINING THE EXTRACT FOR ANTI-OXIDATION, SKIN-AGING PROTECTION AND WRINKLE IMPROVEMENT | POT1, TERT, TERF2 | MAPT 2737/4885MEN1 4165/4885KMT2A 1938/4885 |
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | CYP51A1, ERG28, NISCH | MAPT 4702/4885MEN1 1914/4885KMT2A 1152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.